{"disease":{"id":"with-and-without-myd88-and-or-cd79b-mutations","name":"with and without myd88 and or cd79b mutations"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05319028","title":"Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Calithera Biosciences, Inc","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}